BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 24891813)

  • 1. A novel mutation in the NR2E3 gene associated with Goldmann-Favre syndrome and vasoproliferative tumor of the retina.
    Manayath GJ; Namburi P; Periasamy S; Kale JA; Narendran V; Ganesh A
    Mol Vis; 2014; 20():724-31. PubMed ID: 24891813
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New truncation mutation of the NR2E3 gene in a Japanese patient with enhanced S-cone syndrome.
    Kuniyoshi K; Hayashi T; Sakuramoto H; Mishima H; Tsuneoka H; Tsunoda K; Iwata T; Shimomura Y
    Jpn J Ophthalmol; 2016 Nov; 60(6):476-485. PubMed ID: 27522502
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and molecular characterization of enhanced S-cone syndrome in children.
    Hull S; Arno G; Sergouniotis PI; Tiffin P; Borman AD; Chandra A; Robson AG; Holder GE; Webster AR; Moore AT
    JAMA Ophthalmol; 2014 Nov; 132(11):1341-9. PubMed ID: 25079116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disruption of the human cone photoreceptor mosaic from a defect in NR2E3 transcription factor function in young adults.
    Park SP; Hong IH; Tsang SH; Lee W; Horowitz J; Yzer S; Allikmets R; Chang S
    Graefes Arch Clin Exp Ophthalmol; 2013 Oct; 251(10):2299-309. PubMed ID: 23604511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Swept source optical coherence tomography and optical coherence tomography angiography in pediatric enhanced S-cone syndrome: a case report.
    Minnella AM; Pagliei V; Savastano MC; Federici M; Bertelli M; Maltese PE; Placidi G; Corbo G; Falsini B; Caporossi A
    J Med Case Rep; 2018 Oct; 12(1):287. PubMed ID: 30285900
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Homozygosity for a Recessive Loss-of-Function Mutation of the NRL Gene Is Associated With a Variant of Enhanced S-Cone Syndrome.
    Newman H; Blumen SC; Braverman I; Hanna R; Tiosano B; Perlman I; Ben-Yosef T
    Invest Ophthalmol Vis Sci; 2016 Oct; 57(13):5361-5371. PubMed ID: 27732723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Shared mutations in NR2E3 in enhanced S-cone syndrome, Goldmann-Favre syndrome, and many cases of clumped pigmentary retinal degeneration.
    Sharon D; Sandberg MA; Caruso RC; Berson EL; Dryja TP
    Arch Ophthalmol; 2003 Sep; 121(9):1316-23. PubMed ID: 12963616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel NR2E3 mutations (R104Q, R334G) associated with a mild form of enhanced S-cone syndrome demonstrate compound heterozygosity.
    Hayashi T; Gekka T; Goto-Omoto S; Takeuchi T; Kubo A; Kitahara K
    Ophthalmology; 2005 Dec; 112(12):2115. PubMed ID: 16225923
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel mutation (Cys83Tyr) in the second zinc finger of NR2E3 in enhanced S-cone syndrome.
    Rocha-Sousa A; Hayashi T; Gomes NL; Penas S; Brandão E; Rocha P; Urashima M; Yamada H; Tsuneoka H; Falcão-Reis F
    Graefes Arch Clin Exp Ophthalmol; 2011 Feb; 249(2):201-8. PubMed ID: 20725840
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peculiar fundus abnormalities and pathognomonic electrophysiological findings in a 14-month-old boy with NR2E3 mutations.
    Cassiman C; Spileers W; De Baere E; de Ravel T; Casteels I
    Ophthalmic Genet; 2013; 34(1-2):105-8. PubMed ID: 23039133
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential dimerization of variants linked to enhanced S-cone sensitivity syndrome (ESCS) located in the NR2E3 ligand-binding domain.
    von Alpen D; Tran HV; Guex N; Venturini G; Munier FL; Schorderet DF; Haider NB; Escher P
    Hum Mutat; 2015 Jun; 36(6):599-610. PubMed ID: 25703721
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NR2E3 mutations in enhanced S-cone sensitivity syndrome (ESCS), Goldmann-Favre syndrome (GFS), clumped pigmentary retinal degeneration (CPRD), and retinitis pigmentosa (RP).
    Schorderet DF; Escher P
    Hum Mutat; 2009 Nov; 30(11):1475-85. PubMed ID: 19718767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Developmental or degenerative--NR2E3 gene mutations in two patients with enhanced S cone syndrome.
    Udar N; Small K; Chalukya M; Silva-Garcia R; Marmor M
    Mol Vis; 2011 Feb; 17():519-25. PubMed ID: 21364904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cone Vision Changes in the Enhanced S-Cone Syndrome Caused by NR2E3 Gene Mutations.
    Garafalo AV; Calzetti G; Cideciyan AV; Roman AJ; Saxena S; Sumaroka A; Choi W; Wright AF; Jacobson SG
    Invest Ophthalmol Vis Sci; 2018 Jul; 59(8):3209-3219. PubMed ID: 29971438
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel clinical findings in autosomal recessive NR2E3-related retinal dystrophy.
    Murro V; Mucciolo DP; Sodi A; Passerini I; Giorgio D; Virgili G; Rizzo S
    Graefes Arch Clin Exp Ophthalmol; 2019 Jan; 257(1):9-22. PubMed ID: 30324420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phenotypic features of patients with NR2E3 mutations.
    Pachydaki SI; Klaver CC; Barbazetto IA; Roy MS; Gouras P; Allikmets R; Yannuzzi LA
    Arch Ophthalmol; 2009 Jan; 127(1):71-5. PubMed ID: 19139342
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new mutation in enhanced S-cone syndrome.
    Termühlen J; Alex AF; Glöckle N; Kellner U; Fiedler B; Eter N; Uhlig CE
    Acta Ophthalmol; 2018 Jun; 96(4):e539-e540. PubMed ID: 27573156
    [No Abstract]   [Full Text] [Related]  

  • 18. Two-color pupillometry in enhanced S-cone syndrome caused by NR2E3 mutations.
    Collison FT; Park JC; Fishman GA; Stone EM; McAnany JJ
    Doc Ophthalmol; 2016 Jun; 132(3):157-66. PubMed ID: 27033713
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Electrophysiological verification of enhanced S-cone syndrome caused by a novel c.755T>C NR2E3 missense variant.
    Cehajic-Kapetanovic J; Cottriall CL; Jolly JK; Shanks M; Clouston P; Charbel Issa P; MacLaren RE
    Ophthalmic Genet; 2019 Feb; 40(1):29-33. PubMed ID: 30466340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phenotype Driven Analysis of Whole Genome Sequencing Identifies Deep Intronic Variants that Cause Retinal Dystrophies by Aberrant Exonization.
    Di Scipio M; Tavares E; Deshmukh S; Audo I; Green-Sanderson K; Zubak Y; Zine-Eddine F; Pearson A; Vig A; Tang CY; Mollica A; Karas J; Tumber A; Yu CW; Billingsley G; Wilson MD; Zeitz C; Héon E; Vincent A
    Invest Ophthalmol Vis Sci; 2020 Aug; 61(10):36. PubMed ID: 32881472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.